In this Q&A, Brian Schiro, MD, discusses his preferred approaches to managing shunting. | Read More
Transarterial radioembolization (TARE) is safe and can be an effective method of treatment for patients with intermediate or advanced-stage HCC that does not respond to transarterial chemoembolization (TACE). | Read More
A swivel arm can facilitate easier repositioning of the access arm during and after cone-beam computed tomography (CBCT) acquisition. Researchers reported their findings in the British Journal of Radiology. | Read More
Researchers compared outcomes in patients with single hypervascular hepatocellular carcinoma who were treated only with RFA versus those who were treated with a combination of percutaneous radiofrequency ablation (RFA) and transarterial chemoembolization (RFA/TACE). | Read More
Daniel Brown, MD, FSIR, offers advice on how to avoid potential problems when performing Y-90 procedures. | Read More

Spotlight

In this Q&A, Brian Schiro, MD, discusses his preferred approaches to managing shunting.
Daniel Brown, MD, FSIR, offers advice on how to avoid potential problems when performing Y-90 procedures.
Daniel Sze, MD, PhD, discusses the results of SIRFLOX, FOXFIRE, and FOXFIRE Global trials and how continued investigations in this area, as well as in immunotherapy, may impact the field. Dr. Sze will be presenting at the 2018 Symposium on Clinical Interventional Oncology.